1-7 of 7
Alan F. Wahl
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Humanized Anti-CD40 Antibody, SGN-40, Promotes Apoptosis Signaling and Is Effective in Combination with Standard Therapies in Lymphoma Xenograft Models.

Timothy S. Lewis, PhD, May S.K. Sutherland, Ph.D., Mechthild Jonas, Ph.D., Charles G. Cerveny, M.S., Renee McCormick, B.S., Alan F. Wahl, Ph.D., Jonathan G. Drachman, M.D., Iqbal S. Grewal, Ph.D., Che-Leung Law, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2499.
https://doi.org/10.1182/blood.V108.11.2499.2499
Published: 2006
Journal Articles

Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities

Julie A. McEarchern, Ezogelin Oflazoglu, Leigh Francisco, Charlotte F. McDonagh, Kristine A. Gordon, Ivan Stone, Kerry Klussman, Eileen Turcott, Nico van Rooijen, Paul Carter, Iqbal S. Grewal, Alan F. Wahl, Che-Leung Law
Journal: Blood
Blood (2006) 109 (3): 1185–1192.
https://doi.org/10.1182/blood-2006-07-034017
Published: 2006
Journal Articles

The Humanized Anti-CD40 Monoclonal Antibody SGN-40 Targets Hodgkin’s Disease Cells through Multiple Mechanisms.

Che-Leung Law, PhD, Julie A. McEarchern, PhD, Charles G. Cerveny, MS, Leia M. Smith, PhD, Albina Nesterova, MS, Kristine A. Gordon, BS, Iqbal S. Grewal, PhD, Alan F. Wahl, PhD
Journal: Blood
Blood (2005) 106 (11): 1476.
https://doi.org/10.1182/blood.V106.11.1476.1476
Published: 2005
Journal Articles

A Humanized Anti-CD70 Monoclonal Antibody Targets CD70-Expressing Multiple Myeloma.

Julie A. McEarchern, PhD, Charlotte McDonagh, PhD, Allen Ho, BA, Yu-Tzu Tai, PhD, Leigh Francisco, BS, Kerry Klussman, BS, Carol Morris-Tilden, BS, Kristine Gordon, BS, Ezogelin Oflazoglu, PhD, Kim Kissler, Nikhil Munshi, MD, Kenneth C. Anderson, MD, Steven P. Treon, MD, PhD, Paul Carter, PhD, Alan F. Wahl, PhD, Iqbal S. Grewal, PhD, Che-Leung Law, PhD
Journal: Blood
Blood (2005) 106 (11): 1591.
https://doi.org/10.1182/blood.V106.11.1591.1591
Published: 2005
Journal Articles

SGN-35, an Anti-CD30 Antibody-Drug Conjugate, Exhibits Potent Antitumor Activity for the Treatment of CD30 + Malignancies.

Kevin J. Hamblett, Jeremy Barton, Charles G. Cerveny, Jamie B. Andreyka, Kim M. Kissler, Nicole M. Okeley, Ivan Stone, May K. Sutherland, Michael M. Sun, Peter D. Senter, Alan F. Wahl, Nathan C. Ihle
Journal: Blood
Blood (2005) 106 (11): 610.
https://doi.org/10.1182/blood.V106.11.610.610
Published: 2005
Journal Articles

The Anti-CD30 Monoclonal Antibody SGN-30 Inhibits Hodgkins Disease Growth and Sensitizes Cells to Established Chemotherapeutics.

Charles G. Cerveny, MS, Che-Leung Law, PhD, Renee S. McCormick, BS, Joel S. Lenox, MS, Kevin J. Hamblett, PhD, Lori E. Westendorf, BS, Andrew K. Yamane, BS, Joseph M. Petroziello, MS, Joseph A. Francisco, PhD, Alan F. Wahl, PhD
Journal: Blood
Blood (2004) 104 (11): 2639.
https://doi.org/10.1182/blood.V104.11.2639.2639
Published: 2004
Journal Articles

cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity

Joseph A. Francisco, Charles G. Cerveny, Damon L. Meyer, Bruce J. Mixan, Kerry Klussman, Dana F. Chace, Starr X. Rejniak, Kristine A. Gordon, Ron DeBlanc, Brian E. Toki, Che-Leung Law, Svetlana O. Doronina, Clay B. Siegall, Peter D. Senter, Alan F. Wahl
Journal: Blood
Blood (2003) 102 (4): 1458–1465.
https://doi.org/10.1182/blood-2003-01-0039
Published: 2003